Korean Regulatory Overhaul To Cut Drug RnD, Approval Time
This article was originally published in SRA
Executive Summary
The South Korean government has unveiled a series of regulatory reforms that are designed to step up the competitiveness of the pharma industry and supply drugs in time for public health emergencies.